Reply to Salma Kaochar, Nicholas Mitsiades’ Letter to the Editor re: Umang Swami, Pedro Isaacsson Velho, Roberto Nussenzveig, et al. Association of SPOP Mutations with Outcomes in Men with De Novo Metastatic Castration-sensitive Prostate Cancer. Eur Urol 2020, 78:652–6. Can Mutant SPOP Become an Actionable Biomarker for Precision Oncology Management of Prostate Cancer?: SPOP as a Potential Treatment Selection Marker in Prostate Cancer

Publication date: Available online 6 January 2021Source: European UrologyAuthor(s): Umang Swami, Emmanuel S. Antonarakis, Neeraj Agarwal
Source: European Urology - Category: Urology & Nephrology Source Type: research